Appendix A 317 Wynberg E#, Han AX#, van Willigen HDG, Verveen A, van Pul L, Maurer I, van Leeuwen EM, de Jong MD, Nieuwkerk P, Prins M, Kootstra NA† and de Bree GJ† on behalf of the RECoVERED Study Group. Inflammatory profiles are associated with long covid 6 months after illness onset. [Submitted]. #† = authors contributed equally Additional publications Wynberg E, Toner S, Wendt JK, Visser LG, Breederveld D, Berg J. Business travelers’ risk perception of infectious diseases: where are the knowledge gaps, and how serious are they? J Travel Med. 2013 Jan-Feb;20(1):11-6. doi: 10.1111/j.1708-8305.2012.00673.x. Epub 2012 Dec 4. PMID: 23279225. Wynberg E, Cooke G, Shroufi A, Reid SD, Ford N. Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review. J Int AIDS Soc. 2014 Jan 20;17(1):18809. doi: 10.7448/IAS.17.1.18809. PMID: 24447595; PMCID: PMC3898050. Frigati L, Wynberg E, Maritz J, Holgate S, Cotton MF, Rabie H. Antiretroviral Treatment Initiated in the First Month of Life. Pediatr Infect Dis J. 2017 Jun;36(6):584-587. doi: 10.1097/INF.0000000000001504. PMID: 28027284. Wynberg E, Williams E, Tudor-Williams G, Lyall H, Foster C. Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch? Clin Drug Investig. 2018 Mar;38(3):231238. doi: 10.1007/s40261-017-0605-1. PMID: 29181714. Caniels TG, Bontjer I, van der Straten K, Poniman M, Burger JA, Appelman B, Lavell AHA, Oomen M, Godeke GJ, Valle C, Mögling R, van Willigen HDG, Wynberg E, Schinkel M, van Vught LA, Guerra D, Snitselaar JL, Chaturbhuj DN, Cuella Martin I; Amsterdam UMC COVID-19 S3/HCW study group; Moore JP, de Jong MD, Reusken C, Sikkens JJ, Bomers MK, de Bree GJ, van Gils MJ, Eggink D, Sanders RW. Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination. Sci Adv. 2021 Sep 3;7(36):eabj5365. doi: 10.1126/sciadv.abj5365. Epub 2021 Sep 3. PMID: 34516917; PMCID: PMC8442901. Grobben M, van der Straten K, Brouwer PJ, Brinkkemper M, Maisonnasse P, DereuddreBosquet N, Appelman B, Lavell AA, van Vught LA, Burger JA, Poniman M, Oomen M, Eggink D, Bijl TP, van Willigen HD, Wynberg E, Verkaik BJ, Figaroa OJ, de Vries PJ, Boertien TM; Amsterdam UMC COVID-19 S3/HCW study group; Bomers MK,Sikkens JJ, Le Grand R, de Jong MD, Prins M, Chung AW, de Bree GJ, Sanders RW, van Gils MJ. Cross-reactive antibodies after SARS-CoV-2 infection and vaccination. Elife. 2021 Nov 23;10:e70330. doi: 10.7554/eLife.70330. PMID: 34812143; PMCID: PMC8610423.
RkJQdWJsaXNoZXIy MTk4NDMw